Annotation Detail

Information
Associated Genes
WT1
Associated Variants
WT1 EXON 7 MUTATION
WT1 EXON 7 MUTATION
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
Patients with WT1 (69% exon 7, 15% exon 9) and FLT3-ITD mutations had significantly lower complete remission and higher refractory disease rates than those with wildtype WT1 and without FLT3-ITD following induction therapy in young (16-60) patients with cytogenetically normal AML.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/203
Gene URL
https://civic.genome.wustl.edu/links/genes/49
Variant URL
https://civic.genome.wustl.edu/links/variants/129
Rating
3
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
19221039
Drugs